Cardiac Science Drops Spacelabs Bid, Joins O-T-C Index
This article was originally published in The Gray Sheet
Executive Summary
Cardiac Science remains committed to its long-term growth strategy of leveraging its automatic external defibrillator technology onto an installed base of patient monitors in spite of the firm's Jan. 11 withdrawal of its hostile bid for patient monitor maker Spacelabs Medical.